A novel dual electrochemical immunosensor for the multiplexed determination of adrenocorticotropin (ACTH) and cortisol is reported. Aminophenylboronic acid-modified dual screen-printed carbon electrodes were prepared on which the corresponding ACTH and cortisol antibodies were immobilized. Competitive immunoassays involved biotinylated ACTH and alkaline phosphatase labelled streptavidin, or alkaline phosphatase labelled cortisol. Differential pulse voltammetry upon 1-naphtyl phosphate addition was employed to monitor the affinity reactions. The ranges of linearity were 5.0 10 À5 -0.1 and 0.1-500 ng/mL for ACTH and cortisol. The usefulness of the dual immunosensor was demonstrated by analyzing certified human serum samples with good recoveries.
Introduction
Cortisol (hydrocortisone) is a glucocorticoid produced by the adrenal gland in response to stress and a low level of glucocorticoids in blood. Glucocorticoids play an essential role in the catabolism of peripheral fat, carbohydrates and proteins. In addition, cortisol has anti-inflammatory and immune modulatory effects. The secretion of cortisol is related to that of adrenocorticotropin hormone (ACTH) through corticotropin-releasing hormone (CRH). CRH is synthesized and secreted by the hipothalamus. It stimulates pituitary corticotrophic cells to produce ACTH, a 39-amino acid peptide, which is a fragment of the larger molecule proopiomelanocortin (POMC). ACTH promotes growth and hormone synthesis by the adrenal cortex, and stimulates secretion of glucocorticoids, mineralocorticoids and androgenic steroids [1] . As indicated in the scheme depicted in Figure 1 [2] , the amount of cortisol secreted by the adrenal gland produces an inhibitory effect on both the synthesis and secretion of CRH and ACTH through a negative feedback loop to the hypothalamus and pituitary glands, respectively. Serum levels of ACTH fluctuate with larger peaks in the early morning and nadiring in the late afternoon or early evening, which results in a parallel diurnal rhythm of cortisol secretion, with peak serum levels in the morning and lower levels in the evening. Stress, pain, trauma, hypoxia, hypothermia and hypoglycemia can increase the serum levels of ACTH. Perturbations of the hypothalamus-pituitary adrenal axis result in different clinical forms of hypercorticosolism, including Cushings disease (pituitary adenoma), ectopic ACTH, ectopic CRH, and primary adrenal causes [3] . The diagnosis of Cushings syndrome remains nowadays as one of the most challenging problems in clinical endocrinology [4] . Among other causes, this is because clinical manifestations may overlap with many common clinical conditions. For example, studies have shown that 2-3 % of patients with poorly controlled type 2 diabetes mellitus have unrecognised Cushings syndrome [5] . This diagnosis requires biochemical confirmation of excess cortisol excretion and ACTH determination in order to classify patients with endogenous hypercortisolemia into ACTH independent and dependent [6] . Different levels of ACTH and cortisol concentrations can be found in serum or urine depending on the type of disease. Typically, ACTH is decreased in adrenal-dependent Cushings syndrome and maintained/elevated in Cushings disease [7] . As an example, ACTH levels are undetectable or low (< 5 pg/mL) and cortisol levels are high (> 15 mg/ dL) in patients with primary adrenal tumours or hyperplasia, whereas patients with corticotropin-dependent Cushings syndrome have high plasma ACTH levels (> 15 pg/mL). Therefore, the development of analytical methods able to provide multiplexed determination of ACTH and cortisol hormones should help to perform a faster classification of the patients as well as an easier diagnosis of this kind of diseases. Nevertheless, these methodologies require to be sufficiently sensitive, robust and selective [8] .
Radioimmunoassays and immunochemiluminiscence assays are the most often used methodologies for clinical determination of cortisol and ACTH independently [4, 7] .
However, in some cases, the assays are not sensitive enough to determine the low concentrations of ACTH involved in ACTH-independent Cushings syndrome [7] .
Because of their high sensitivity, rapid response and usability, electrochemical immunosensors have demonstrated to be excellent alternatives in clinical analysis of selected analytes [9, 10] . Our group has developed recently electrochemical immunosensors for the determination of some hormones. For example, testosterone was determined in serum using configurations based on the immobilization of anti-testosterone antibodies on gold nanoparticles-carbon nanotubes-Teflon composite electrodes [11] . Magnetic electrochemical immunosensors were also developed for testosterone [12] , prolactin [13] and cortisol [14] . Moreover, the ultrasensitive detection of ACTH was accomplished by using disposable phenylboronic-modified electrochemical immunosensors [15] .
In this paper, we report the preparation of a dual electrochemical immunosensor for the multiplexed determination of ACTH and cortisol, which satisfies the requirements of sensitivity, selectivity and reproducibility needed for clinical applications. Aminophenylboronic acid-modified electrodes were prepared on which the corresponding ACTH and cortisol antibodies were immobilized. Competitive immunoassays were then performed and differential pulse voltammetry upon 1-naphtyl phosphate addition was employed to monitor the affinity reactions. The usefulness of the approach was demonstrated by its application to serum samples.
Experimental

Apparatus and Electrodes
Electrochemical measurements were carried out using an 1030 B Electrochemical Analyzer from CH Instruments. Dual screen-printed electrodes (C 1110 DropSens, Oviedo, Spain) consisted of two elliptic carbon working electrodes, a carbon counter electrode and a silver pseudo-reference electrode. All experiments were performed at room temperature. A P-Selecta ultrasonic bath, and a P-Selecta Agimatic magnetic stirrer, all distributed by Scharlab, Madrid, Spain, were also used.
Reagents and Solutions
Anti-ACTH C-terminal was purchased from Fitzgerald MA, USA. 1.05 mg/mL solutions were prepared in phosphate buffer solution of pH 7.4 (PBS). Diluted solutions of both ACTH (Genway Biotech, CA, USA) and biotinylated ACTH (Biotin-ACTH) (AnaSpec, CA, USA) were prepared in PBS. Murine monoclonal anti-cortisol was from East Coast Bio, ME, USA. 2.39 mg/mL solutions were prepared in PBS. Cortisol labelled with alkaline phosphatase in position 3 (cortisol-AP), with an enzyme activity of 1840 U/mg, was obtained from Cal Bioreagents, CA, USA. Diluted solutions were prepared daily in Tris buffer solution of pH 7.2 which also contained 2 % BSA. A 500 mg/mL stock solution of unlabelled cortisol (Aldrich > 98 %) in methanol was prepared. More diluted solutions were prepared in Tris buffer solution of pH 7.2. A 50 mM Tris (Scharlau, 99 %) and 20 mM NaCl (Scharlau, 99 %) buffer solution of pH 7.2, and a 0.1 M Trizma base (Sigma, 99 %) and 1 mM magnesium chloride (Panreac, 99 %) buffer solution of pH 9.0, were employed. 1-Naphthyl phosphate monosodium salt monohydrate (1-NPP, Sigma) was also used. 0.05 M 1-NPP solutions were prepared daily in Trizma base buffer of pH 9.0. BSA (Gerbu, tipo VH) was also used. 2 % BSA solutions in both PBS and Tris buffer solution of pH 7.2 were used. Streptavidin labelled with alkaline phosphatase (Strept-AP) (Sigma) was also employed. Diluted solutions were prepared in Tris buffer solution of pH 7.2. 4-Aminobenzoic acid (ABA, Across), 4-amino phenyl boronic acid (APBA, Sigma), 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide hydro-chloride (EDC) (Sigma) and N-hydroxysuccinimide (NHS) (Sigma) were also used.
Samples
Samples containing different ACTH and cortisol mixtures were analyzed. These were prepared from certified lyophilised human sera containing 10 mg/mL ACTH (NIBSC, 74/555) or 277 ng/mL cortisol (European Reference Materials, ERM-DA 193, Sigma), in the reconstituted serum, respectively.
Procedures
Modification of Dual SPC Electrodes
Figure 2a displays a scheme of the employed procedure. Firstly, 20 mg of 4-aminobenzoic acid were dissolved in 2 mL 1 M HCl and cooled with ice. Then, the corresponding diazonium salt was prepared by adding dropwise a 2 mM NaNO2 aqueous solution (38 mL for each 200 mL of 4-aminobenzoic acid solution) with constant stirring. Next, 40 mL of the resulting solution were spotted onto the SPC electrodes and ten successive voltammetric cycles from 0.0 to À1.0 V (v = 200 mV/s) were scanned. Finally, the modified electrodes were washed thoroughly with water and methanol, and dried at room temperature. In a second step, 10 mL of an EDC/NHS mixture (0.1 M each) aqueous solution were spotted onto the modified electrodes and left to react for 1 h. After rinsing with water and methanol and allowing drying, 10 mL of a 50 mM 3-aminophenylboronic acid were placed onto the electrodes. After 3 h incubation, the resulting aminophenylboronic acid-modified electrodes (APBA/SPCEs) were thoroughly rinsed with water and methanol and allowing drying at room temperature.
Preparation of the Immunosensors
ACTH and cortisol immunosensors were prepared on APBA/SPCE1 and APBA/SPCE2 modified electrodes, respectively. 4 mL of 30 mg/mL anti-ACTH and 50 mg/mL anti-cortisol solutions in PBS were dropped onto the respective electrode and left stand overnight at 8 8C. Then, 4 mL of a 2 % BSA blocking solution were deposited onto both electrodes and incubation was allowed for 1h at room temperature. Competitive immunoassays were performed by spotting 4 mL of a mixture solution of ACTH (or the sample) and 1 mg/mL biotinylated-ACTH (biotin-ACTH) on the anti-ACTH/APBA/SPCE1 electrode, and 4 mL of a mixture solution of cortisol (or the sample) and 1 mg/mL alkaline phosphatase-labelled cortisol 2 % BSA (AP-cortisol) on the anti-cortisol/APBA/SPCE2 electrode allowing incubation at both electrodes for 45 min at 8 8C. Thereafter, 4 mL of 2 mg/mL alkaline phosphatase-labelled streptavidin (Strept-AP) and 4 mL of Tris buffer solution of pH 7.2 were added to the Biotin-ACTH/anti-ACTH/ APBA/SPCE1 and the cortisol-AP/anti-cortisol/APBA/ SPCE2, respectively. After 60 min incubation at 8 8C, 45 mL Trizma buffer plus 5 mL of 0.05 M 1-NPP solution were deposited onto the electrodes and allowed to stand for 8 minutes. Differential pulse voltammograms were recorded over the À0.15 to + 0.60 V range to obtain the electroanalytical signals.
Multiplexed Determination of ACTH and Cortisol in Serum
Lyophilised human sera containing ACTH or cortisol were reconstituted, respectively, in 2.5 mL or 1.25 mL Milli-Q water to obtain 10 mg/mL ACTH, or 277 ng/mL cortisol stock solutions. From these stock solutions, different ACTH-cortisol mixtures also containing Biotin-ACTH or cortisol-AP conjugates were prepared and spotted on the anti-ACTH/APBA/SPCE1 anti-cortisol/ APBA/SPCE2 electrodes. Thereafter, the ACTH and cortisol were simultaneously determined by applying the procedure described above which involved simultaneous measurement of the respective DPV peak current values at each electrode and interpolation into the linear portion of the corresponding calibration plot obtained with ACTH or cortisol standard solutions.
Results and Discussion
The methodologies employed in the design and functioning of the dual immunosensor are illustrated in Figure 2 .
As it is described in Section 2.4.1, firstly, SPCE1 and SPCE2 were modified with boronic acid as described in the Experimental section (Procedure 2.4.1.). Subsequently, anti-ACTH and anti-cortisol antibodies were attached to the resulting APBA/SPCEs through the oriented boronic acid-saccharide bonds [16] . After a blocking step with BSA, competitive assays between ACTH and Biotin-ACTH, and between cortisol and cortisol-AP for the binding sites of the respective antibodies were accomplished. In the case of the ACTH immunosensor a further conjugation with streptavidin labelled with alkaline phosphatase was carried out. In both cases, 1-NPP was employed as AP substrate to detect the immunosensing events and the electrochemical oxidation of the generated enzyme reaction product, 1-naphtol, was measured by differential pulse voltammetry. Cyclic voltammetry from a 5 mM [Fe(CN)6] 3À / 4À 0.1 M KCl solution was employed to characterize the modified electrode surface of SPCE1 and SPCE2 upon the different modification steps ( Figure 3 ). As expected, voltammograms 1 to 4 were similar at both electrodes.
Modification of SPCEs with ABA produced a sharp decrease in the voltammetric response due to the electrostatic repulsion between the redox probe and the negatively charged carboxylate groups. Upon activation of the surface-confined carboxyl groups with EDC/NHS and attachment of APBA moieties to the electrode surface through the formation of amide bonds (voltammograms 3 and 4), an increase in the voltammetric response to the redox probe was observed as a consequence of the electrode negative surface charge neutralization. Conversely, the peak current measured at the anti-ACTH/APBA/ SPCE1 (curve 5) was remarkably higher than that obtained with the anti-cortisol/APBA/SPCE2 (curve 5'), thus reflecting differences in the antibodies loadings and characteristics.
Optimization of the Experimental Variables Involved in the Immunosensors Responses
All variables involved in the electroanalytical responses of the dual immunosensor for ACTH and cortisol were optimized. Firstly, the respective antibody loadings into the APBA/SPCE1 and APBA/SPCE2 were evaluated by checking the DP voltammetric responses obtained with different immunosensors prepared with no ACTH or cortisol and by spotting 4 mL of anti-ACTH or anti-cortisol solutions prepared in the 0 to 80 mg/mL antibody concentration range, respectively. 1 mg/mL Biotin-ACTH M 1-NPP were used in these experiments. Figure 4a shows as the measured i p values increased both at the ACTH and cortisol immunosensors with the antibody loading, exhibiting a remarkably lower increase from 30 mg/mL anti-ACTH and 50 mg/mL anti-cortisol. Therefore, these antibodies loading values were selected for further work. Furthermore, anti-ACTH/APBA/SPCE1 and anti-cortisol/ APBA/SPCE2 were allowed to stay overnight at 8 8C.
In order to reduce non-specific binding of immunoreagents on the electrodes surfaces, a blocking step with BSA was accomplished. In a first approach, the experimental conditions optimized previously for ACTH (2 % BSA and 1h incubation time) [15] were used. Although the unspecific responses from Strept-AP at SPCE were found to be always lower than 10 % of the signals obtained with the Strept-AP/Biotin-ACTH/anti-ACTH/ APBA/SPCE, the nonspecific binding was remarkably higher when cortisol-AP was involved. DP voltammograms recorded at SPCEs from cortisol-AP solutions without blocking with BSA (curve 1) and with a blocking step with 2 % BSA for different incubation times (curves 2 and 3). The DP voltammograms recorded upon spotting a cortisol-AP-2 % BSA mixture solution with and without a further incubation step with 2 % BSA are also displayed (curves 4 and 5). As it can be observed, the lower unspecific signal was obtained when the cortisol-AP solution was prepared in the presence of 2 % BSA, and the electrode was also blocked with 2 % BSA during 1 h incubation time. Using these experimental conditions, Figure 5b compares the differential pulse voltammograms obtained in the measurement of the specific response of the cortisol-AP/anti-cortisol/APBA/SPCE immunosensor for 0 ng/mL cortisol (curve 1) and 250 ng/mL cortisol (curve 2), with the unspecific voltammetric signal (curve 3). As it can be seen, a large analytical signal-tobackground current ration could be obtained thus allowing the sensitive determination of cortisol to be performed with the dual immunosensor.
The concentration of Biotin-ACTH was optimized by preparing various Strept-AP/Biotin-ACTH/anti-ACTH/ APBA/SPCE immunosensors which were incubated in Biotin-ACTH solutions with different concentrations ranging between 0 and 2 mg/mL. Figure 4b shows as the DP peak current measured for 0 ng/mL ACTH exhibited a rapid increase from 0 to 0.75 mg/mL and levelled off for higher Biotin-ACTH concentrations. Accordingly, 1 mg/ mL Biotin-ACTH concentration was selected for further work. Moreover, 45 min at 8 8C was the optimized value for incubation of the anti-ACTH/APBA/SPCE immunosensors with the Biotin-ACTH solution (results not shown).
As it was illustrated in Figure 1 , Strept-AP was used as the labelled protein in the immunosensor design to determine ACTH. The conjugate concentration was optimized by testing the voltammetric response of different immunosensors incubated with Strept-AP in the 0 to 3 mg/mL range. The obtained results (Figure 4c ) revealed a rapid current increase up to 2 mg/mL Strept-AP and a practically constant value for larger conjugate concentrations. Therefore, that concentration, which probably corresponded to the saturation of the biotinylated ACTH, was selected for further work. Moreover, optimal results were achieved when the incubation step with the Strept-AP solution was performed at 8 8C for 60 minutes (results not shown).
Similarly, the cortisol-AP concentration was optimized in the case of the cortisol immunosensor preparation. This was made by checking the DP voltammetric response of various immunosensors incubated with the conjugate in the 0 to 2 mg/mL concentration range. Figure 4d shows a rapid increase in the ip value with the conjugate concentration at the lower cortisol-AP concentration values reaching a constant response from 1 mg/L, indicating saturation of the antibodies binding sites. Using this conjugate concentration, an incubation time of 45 min at 8 8C resulted appropriate to allow an adequate competition between cortisol and cortisol-AP for the binding positions of anti-cortisol.
As it was mentioned already, 1-NPP was the alkaline phosphatase substrate employed to generate the enzymatic product suitable to be voltammetrically detected at the modified electrodes surface for both immunosensors [14] . Thus, the influence of 1-NPP concentration on the simultaneous differential pulse voltammetric responses of both the Strept-AP/Biotin-ACTH/anti-ACTH/APBA/SPCE1 and cortisol-AP/anti-cortisol/APBA/SPCE2 immunosensors was evaluated in the 5 10 À6 to 0.1 M range (results not shown). The highest peak current values were achieved using a 50 mM 1-NPP concentration, which represented a relatively high value suitable to ensure that the enzyme reaction rate depended only on the enzyme concentration. Finally, 8 min was selected as an optimal hydrolysis time of the enzyme substrate. The possible crosstalk between the two SPCEs and reaction products was evaluated by recording DP voltammograms at the immunosensors where mixture solutions of ACTH and cortisol were deposited. Figure 6 compares the voltammograms recorded from 50 ng/mL ACTH plus 1 mg/mL cortisol-AP (curve 1) and only 1 mg/mL cortisol-AP (curve 2) at the cortisol-AP/anti-cortisol/APBA/SPCE2. Similarly, voltammograms recorded with the Strept-AP/Biotin-ACTH/anti-ACTH/APBA/SPCE1 for both 500 ng/mL cortisol plus 1 mg/mL Biotin-ACTH (curve 3) and only 1 mg/mL Biotin-ACTH (curve 4) are also displayed in Figure 6 . As it can be observed, no significant differences in the voltammetric responses with each immunosensor were found in the presence and in the absence of the non-target analyte, thus demonstrating that no appreciable cross-talking occurred with the developed dual immunosensor.
Analytical Characteristics for ACTH and Cortisol
Determination with the Dual Immunosensor (2) and unspecific DPV responses obtained with an anticortisol/APBA/SPCE immunosensor for 0 ng/mL (1) and 250 ng/mL (2) cortisol; the unspecific response (3) was measured as in a) (5) . 50 mg/mL anti-cortisol; 1 mg/mL cortisol-AP; 0.05 M 1-NPP. in Table 1 . The i p vs. concentration curves were fitted by non-linear regression using the Sigma Plot data analysis software. The adjusted equation was:
with r = 0.998 (ACTH) and r = 0.999 (cortisol), where i max and i min were the maximum and minimum current values of the calibration graphs: 2.92 AE 0.07 and 0.093 AE 0.006 mA, respectively, for ACTH, and 6.64 AE 0.01 and 0.038 AE 0.008 mA, respectively, for cortisol. As can be seen in Table 1 , both calibration graphs provided wide linear concentration ranges, this being in agreement with the low Hill slope values [17] . The limits of detection were calculated from the equation [18] :
where s is the standard deviation (n = 10) of the zero value (the i p value measured in the absence of ACTH or cortisol). This value was AE 0.24 mA for ACTH and AE 0.12 mA for cortisol, with relative standard deviations of 6.3 % (n = 5) for both compounds. Accordingly, LOD values of 40 pg/L ACTH and 37 pg/mL cortisol were achieved. These analytical characteristics are much better than those reported previously in the literature for the individual determination of ACTH or cortisol using other approaches and similar to those reported recently by our group. In fact, various immunoassays were proposed for the determination of ACTH based on different antibodies and using radioactivity, chemiluminiscence or fluorescence as detection techniques. These methodologies allowed ranges between a few units up to various hundreds of ng/L ACTH to be covered [19] [20] [21] , concentrations that are much larger than those appearing in the linear range obtained for this hormone with the developed Strept-AP/ Biotin-ACTH/anti-ACTH/APBA/SPCE1 immunosensor. On the other hand, the electrochemical immunosensor for ACTH previously described by our group provided a detection limit of 18 pg/L [15] . This slight difference is most likely due to the remarkably smaller surface area of the SPCE working electrodes in the dual device (5.6 mm 2 ) with respect to that of the single SPCE used for the individual determination of ACTH (12.56 mm 2 ). Regarding cortisol, the limit of detection achieved in this work with the cortisol-AP/anti-cortisol/APBA/SPCE2 immunosensor was one half of the smallest reported value (72 pg/mL) obtained by a non-competitive colorimetric ELISA using cortisol-poly(l-lys) conjugates and HRPcortisol [22] . Comparing with a previous immunosensor reported by our group using SPCEs and protein-A functionalized magnetic microparticles [14] , the limit of detection is approximately ten times higher but the range of linearity is wider. This difference is due not only to the smaller electrochemical surface area of SPCE2 compared with the conventional SPCEs used in [14] , but also to the ability of magnetic microparticles to immobilize a high concentration of biomolecules onto the electrode surface allowing the achievement of high sensitivities.
It is important to remark that the limits of detection achieved for both analytes with the dual immunosensor fulfils the requirements for the analysis of the hormones in human serum considering that in typical diseases the ACTH and cortisol concentrations are around 0.005 ng/ mL and 150 ng/mL, respectively.
The reproducibility of the DP voltammetric measurements was evaluated by carrying out repetitive assays in the same day and in different days for solutions containing no ACTH or cortisol and for 1 pg/mL ACTH or 10 ng/mL cortisol (concentrations similar to the respective EC50 values). Relative standard deviation (RSD) values of 6.3 % (n = 8) were obtained for the assays performed on the same day with both ACTH and cortisol immunosensors, whereas the RSD values (n = 8) were 7.6 % when no ACTH was present and 8.5 % for 1 pg/mL ACTH, and 7.9 % without cortisol and 8.1 % for 10 ng/ mL cortisol, when the measurements were carried out on different days. The storage stability of the anti-ACTH/ APBA/SPCE1, Strept-AP/Biotin-ACTH/anti-ACTH/ APBA/SPCE1, anti-cortisol/APBA/SPCE2 and cortisol-AP/anti-cortisol/APBA/SPCE2 immunosensors was also evaluated. In order to do that, different bioelectrodes were prepared on the same day and stored in a refrigerator at 4 8C. Then, each bioelectrode was used to construct the corresponding immunosensor and to measure the voltammetric response for 5 mM 1-NPP in the absence of ACTH or cortisol. As an example, Figure 8 shows the control chart displaying the results obtained for a period of time of 21 days for anti -ACTH/APBA/SPCE1 ( * ) and anti-cortisol/APBA/SPCE2 ( * ) immunosensors. Each point in the control chart represented the mean value of three successive measurements and the control limits were set at AE 3 times the standard deviation calculated for the whole series of experiments. As it can be seen, both bioelectrodes yielded voltammetric responses that remained inside the control limits for 15 days. On the other hand, the storage stability of the bioelectrodes constructed with all the bioconjugates, Strept-AP/Biotin-ACTH/anti-ACTH/APBA/SPCE1 and cortisol-AP/anticortisol/APBA/SPCE2 was much poorer retaining only approximately 30 % of the initial value after twelve days from their preparation.
Simultaneous Determination of ACTH and Cortisol in Certified Human Sera
The usefulness of the dual immunosensor for the multiplexed analysis of real samples was evaluated by analyzing certified human serum samples. Calibration graphs for ACTH and cortisol were constructed from the reconstituted serum by appropriate dilution with the respective working buffer solutions in the 0.01 to 100 pg/mL ACTH and 0.1 to 200 ng/mL cortisol concentration ranges. It was observed that the calibration graphs constructed in diluted sera fifted perfectly with the calibration graphs obtained with standard solutions of the analytes depicted in Figure 6 . Actually, the linear ranges of the calibration plots recorded with the serum samples exhibited slope values of À0.507 AE 0.006 mA (r = 0.999) for ACTH, and À1.6 AE 0.1 mA (r = 0.998) for cortisol, which were very similar to those obtained for ACTH and cortisol standard solutions (À0.510 mA and À1.59 mA). These results, showing that no significant matrix effect existed, allowed the simultaneous determination of ACTH and cortisol to be performed by interpolation of the measured ip values into the calibration plots constructed with ACTH and cortisol standard solutions. The results obtained in the analyses carried out at four different concentration levels for each hormone in the samples are summarized in Table 2 .
As it can be seen, recoveries ranged between 98.3 AE 0.1 and 102 AE 3 % for ACTH and 99 AE 9 and 104 AE 8 % for cortisol. These results demonstrated fairly well the usefulness of the developed dual immunosensor for the multiplexed analysis of low ACTH and cortisol concentrations in human sera with practically no sample treatment.
Conclusions
In this paper, the development of an electrochemical multiple-analyte immunosensor for the ultrasensitive multiplexed determination of ACTH and cortisol hormones in human serum is reported for the first time. The immunosensing approach involves the immobilization of anti-ACTH or anti-cortisol onto phenylboronic acid-modified dual screen printed carbon electrodes, competitive immunoassay implying biotinylated ACTH and alkaline phosphatase labelled streptavidin, or alkaline phosphatase labelled cortisol. and differential pulse voltammetric transduction of the affinity reactions. The developed dual immunosensor exhibits excellent analytical performance in terms of sensitivity, selectivity, wide range of quantifiable antigen concentrations, and inter-assay reproducibility. Therefore, this multiple-analyte immunosensor can be envisaged as a useful and affordable analytical tool for the rapid determination of ACTH and cortisol in clinical applications, as it has been outlined with the results obtained for the analysis of certified human serum samples. 
